Abstract
Surgical site infections (SSIs) post‐cardiothoracic surgery represent a significant challenge in patient care. Understanding the risk factors contributing to SSIs is essential for improving surgical outcomes and patient safety. A comprehensive retrospective analysis was conducted at our institution from January 2021 to December 2022. This study included 30 patients with SSIs and 60 without, following cardiothoracic open surgery. Data were collected on various variables, including hypertension, anaemia, operation time, hospital stay, alcohol consumption, smoking habits, Body Mass Index, age, and drainage tube placement. Univariate and multivariate logistic regression analyses were employed using SPSS software to identify significant predictors of SSIs. Univariate analysis indicated a strong correlation between SSIs and factors like smoking, diabetes mellitus, drainage tube placement, anaemia, and significant intraoperative blood loss (≥800 mL). These factors were statistically significant with p‐values < 0.05. Multivariate logistic regression further confirmed the impact of these factors, with high odds ratios indicating a substantial increase in SSI risk associated with these conditions. This study highlights intraoperative blood loss, anaemia, drainage tube placement, smoking, and diabetes mellitus as key risk factors for SSIs post‐cardiothoracic surgery. Recognising and addressing these factors through targeted preventive measures is crucial in clinical practice to reduce the incidence of SSIs and improve postoperative care in cardiothoracic surgery.
Keywords: cardiothoracic surgery, logistic regression analyses, risk factors, surgical site infections
1. INTRODUCTION
Cardiothoracic surgery, a critical component in modern cardiac and thoracic medicine, has undergone remarkable developments over recent decades. This field has expanded the boundaries of medical intervention, enabling the treatment of complex heart and lung diseases that were once considered beyond the reach of surgical remedy. 1 , 2 Particularly, the advancement in open chest surgery techniques has revolutionised the practice, allowing for intricate operations to be conducted with greater accuracy and yielding superior patient outcomes. These innovative techniques represent a significant shift in surgical methodology, broadening the scope of treatable cardiothoracic conditions and enhancing patient prognosis. 3 , 4
However, the progress in cardiothoracic surgery is accompanied by notable challenges, particularly in the realm of postoperative complications. Surgical site infections (SSIs) following open chest procedures stand out as a critical concern, posing substantial risks to patient recovery and overall health outcomes. 5 These infections can significantly complicate the postoperative period, leading to extended hospital stays, escalated healthcare expenses, and in more severe scenarios, increased patient morbidity and mortality. 6 The aetiology of SSIs in the context of cardiothoracic surgery is multifaceted, encompassing a variety of contributory factors. These include, but are not limited to, the patient's health status prior to surgery (preoperative condition), the conditions within the operating environment (intraoperative factors), and the management of the patient's care after the operation (postoperative care). Preoperative factors can significantly influence the risk of SSIs. 7 , 8 Conditions such as diabetes, immunosuppression, or poor nutritional status can predispose patients to a higher risk of infection. Similarly, habits like smoking or alcohol consumption may adversely affect wound healing and infection resistance. Intraoperatively, the duration and complexity of the surgery, along with the sterility of the surgical environment, play crucial roles. Longer surgical times and complex procedures are often associated with a higher risk of SSIs. 9 Postoperative care, including wound care management and the monitoring and control of any comorbid conditions, is equally vital. Optimal postoperative care, including wound care management techniques, and rigorous monitoring and management of comorbid conditions like glycaemic control in patients with diabetes, has been shown to significantly reduce SSI risk. 10 , 11
Understanding and mitigating these risk factors is essential for improving patient outcomes following cardiothoracic surgery. This demands a comprehensive approach, encompassing preoperative patient assessment and optimisation, adherence to stringent intraoperative sterile techniques, and diligent postoperative care and monitoring. By addressing these aspects, it is possible to significantly reduce the incidence of SSIs, thereby enhancing the overall success and safety of cardiothoracic surgical procedures. The primary objective of this study is to conduct a comprehensive, retrospective analysis of the risk factors contributing to the development of SSIs following cardiothoracic open surgery, utilising both univariate and multivariate logistic regression analyses to identify significant predictors of SSIs among postoperative patients. Through analysis of clinical data, this research aims to delineate the specific risk factors that significantly influence the incidence of SSIs in postoperative cardiothoracic patients. By identifying these factors, the study seeks to provide valuable insights that can inform clinical guidelines and improve patient outcomes.
2. MATERIALS AND METHODS
2.1. Study design
A comprehensive retrospective analysis was undertaken at our institution to delineate the risk factors implicated in the occurrence of SSIs following Cardiothoracic Open Surgery. This investigation spanned a period from January 2021 to December 2022. The research focused on a cohort of 30 patients who developed SSIs following their surgeries. These individuals were subsequently classified into the case group for detailed analysis. To facilitate a robust comparative analysis, a control group comprising 60 patients, who underwent similar procedures within the same timeframe but did not develop SSIs, was constituted. This approach was pivotal in ensuring the methodological soundness and comparability of the two groups. In accordance with ethical research practices, all participants in the study provided informed consent. The study's design, objectives, and methodologies were subjected to a thorough review and approval process by the ethics committee of our institution.
2.2. Inclusion and exclusion criteria
For this extensive analysis of risk factors associated with SSIs post‐cardiothoracic open surgery, the study incorporated patients aged 18 years and older who underwent cardiothoracic open surgery within the timeframe from January 2021 to December 2022. Included were individuals within a postoperative window of up to 30 days, aligning with the commonly observed period for the emergence of SSIs. Essential to the study's rigour was the availability of complete medical records for each participant, encompassing preoperative, intraoperative and postoperative details. A fundamental requirement for inclusion was the provision of written informed consent by the patients, ensuring their voluntary participation and comprehension of the study's scope and purpose.
The study delineated clear exclusion criteria to maintain the integrity of its findings. Patients with a history of chronic infections or existing infections at the surgical site prior to their cardiothoracic surgery were excluded. This exclusion was crucial to avoid confounding variables that could influence the study's focus on postoperative SSIs. Additionally, individuals who underwent any additional surgical interventions within 30 days following their cardiothoracic surgery were not considered for the study. This measure was taken to isolate the risk factors associated specifically with cardiothoracic open surgery and to eliminate the potential influence of other surgical procedures. Furthermore, patients with known immunocompromising conditions, such as HIV/AIDS, chronic steroid use, or those undergoing chemotherapy and on immunosuppressive therapy at the time of their surgery, were also excluded. This criterion was set to ensure that the study's results accurately reflected the risk factors for SSIs in the absence of significant underlying immune system alterations.
2.3. Data collection
In our endeavour to identify factors potentially contributing to surgical outcomes, particularly in the context of SSIs, we meticulously collected comprehensive patient data. The information gathered encompassed a wide array of variables, including hypertension, anaemia, operation time, length of hospital stay, alcohol consumption, smoking habits, Body Mass Index (BMI), age and the use of drainage tubes post‐surgery. Additionally, we included patients' history of urinary tract infections, diabetes mellitus and the amount of blood lost during surgery (intraoperative blood loss). The rationale behind selecting these specific variables was to thoroughly evaluate an array of factors that could potentially influence both surgical and post‐surgical outcomes. This comprehensive approach was critical in understanding the multifaceted nature of SSIs. Adherence to ethical standards in data collection was paramount, ensuring that all information was gathered with precision and integrity, thereby bolstering the accuracy and reliability of our subsequent analyses.
2.4. Statistical analysis methods
Statistical analyses were meticulously performed using SPSS software (Version 27.0). In this study, statistical analyses were performed using both univariate and multivariate approaches to identify significant predictors of surgical outcomes, particularly focusing on SSIs. Univariate analysis was conducted initially to examine the association between each individual variable (such as hypertension, smoking habits, operation time, etc.) and the occurrence of SSIs. This analysis utilised chi‐square tests for categorical variables and Student's t‐tests for continuous variables. Following the identification of significant factors in the univariate analysis, a multivariate logistic regression model was employed. This approach allowed for the assessment of the independent effect of each variable while controlling for potential confounders. The multivariate model was instrumental in determining the variables that held significant predictive value for SSIs when considered in conjunction with other risk factors. The level of statistical significance was set at a p‐value of <0.05 for all tests.
3. RESULTS
3.1. Results from the univariate analysis of risk factors for SSIs
The univariate analysis of risk factors associated with SSIs post‐cardiothoracic surgery revealed distinct patterns among the 30 infected and 60 non‐infected patients. This analysis focused on several key patient characteristics and intraoperative factors. Factors such as smoking, diabetes mellitus and drainage tube placement showed a strong statistical correlation with the development of SSIs. These factors not only had high chi‐square values but also significant p‐values (p < 0.01), underscoring their potential role in increasing SSI risk. Particularly, the highest chi‐square values were observed for smoking and diabetes mellitus, indicating a strong association with SSIs. Additionally, anaemia and intraoperative blood loss of more than 800 mL were also found to be significantly associated with SSIs, both showing p‐values of <0.05. These findings suggest that these factors may contribute to the increased vulnerability of patients to SSIs following surgery. Conversely, factors such as hypertension, length of hospital stay exceeding 14 days, alcohol consumption, age over 60 years and a BMI of 25 kg/m2 or higher were not significantly associated with SSIs. This is indicated by their higher p‐values and lower chi‐square values. Interestingly, operation time of 7 h or more showed a borderline p‐value of 0.058, suggesting a potential but less definitive association with SSI risk. These results highlight the need for focused attention on specific risk factors, especially smoking, diabetes mellitus, drainage tube placement, anaemia and significant intraoperative blood loss, in the management and prevention strategies for SSIs in patients undergoing cardiothoracic surgery (Table 1).
TABLE 1.
Univariate analysis for factors influencing surgical site infections.
Factors | Infected (n = 30) | Non‐infected (n = 60) | χ 2 | p‐Value |
---|---|---|---|---|
Hypertension | 14 (46.7%) | 27 (45.0%) | 0 | 1 |
Hospital stay (>14 days) | 16 (53.3%) | 28 (46.7%) | 0.14 | 0.709 |
Alcohol consumption | 16 (53.3%) | 28 (46.7%) | 0.14 | 0.709 |
Age (≥60 years) | 20 (66.7%) | 44 (73.3%) | 0.17 | 0.681 |
Body Mass Index (≥25 kg/m2) | 19 (63.3%) | 33 (55.0%) | 0.28 | 0.597 |
Operation time (≥7 h) | 17 (56.7%) | 20 (33.3%) | 3.59 | 0.058 |
Anaemia | 11 (36.7%) | 9 (15.0%) | 4.25 | <0.05 |
Intraoperative blood loss (≥800 mL) | 12 (40.0%) | 10 (16.7%) | 4.55 | <0.05 |
Drainage tube placement | 26 (86.7%) | 22 (36.7%) | 18.13 | <0.01 |
Smoking | 23 (76.7%) | 12 (20.0%) | 24.69 | <0.01 |
Diabetes mellitus | 21 (70.0%) | 9 (15.0%) | 24.81 | <0.01 |
3.2. Results of multivariate logistic regression on risk factors for SSIs
The results of the multivariate logistic regression analysis, as presented in Table 2, elucidate the influence of various factors on the occurrence of SSIs following cardiothoracic surgery. This analysis provided insights into the relative impact and statistical significance of each factor, contributing to a deeper understanding of SSI risk factors. Significant contributors to the risk of SSIs included intraoperative blood loss of 800 mL or more, anaemia, placement of drainage tubes, smoking habits and the presence of diabetes mellitus. Each of these factors demonstrated a statistically significant association with the incidence of SSIs, as indicated by their respective p‐values being <0.05. The ORs and 95% CIs for these factors highlight their respective influences. For instance, the odds of developing SSIs were notably higher in patients with significant intraoperative blood loss, with an OR of 2.877. Similarly, the presence of anaemia increased the odds of SSIs to 3.355, underlining its substantial impact on patient outcomes. The placement of drainage tubes was another critical factor, showing an OR of 3.445. This finding suggests that the use of drainage tubes significantly elevates the risk of SSIs, warranting careful consideration in postoperative care. Smoking and diabetes mellitus were also identified as significant risk factors. Patients with a history of smoking had an OR of 2.378 for developing SSIs, while those with diabetes mellitus had an OR of 2.711. These results point to the importance of considering patient lifestyle and comorbidities in the management of postoperative complications.
TABLE 2.
Multivariate logistic regression analysis for factors influencing surgical site infections.
Factors | β value | Standard error | Wald value | Odds ratio | 95% CI for OR | p‐Value |
---|---|---|---|---|---|---|
Intraoperative blood loss (≥800 mL) | 0.266 | 0.922 | 3.134 | 2.877 | 1.006–3.826 | 0.043 |
Anaemia | 0.297 | 1.154 | 3.532 | 3.355 | 1.176–4.068 | 0.041 |
Drainage tube placement | 0.312 | 1.267 | 3.693 | 3.445 | 1.196–4.416 | 0.034 |
Smoking | 0.225 | 0.992 | 2.544 | 2.378 | 1.195–3.516 | 0.024 |
Diabetes mellitus | 0.257 | 1.164 | 2.916 | 2.711 | 1.193–3.695 | 0.019 |
4. DISCUSSION
The occurrence of SSIs following cardiothoracic open surgery remains a significant clinical challenge, impacting patient outcomes, prolonging hospital stays and increasing healthcare costs. 12 Cardiothoracic surgery, due to its complexity and the critical nature of the operated organs, inherently carries a higher risk of postoperative complications, including SSIs. Understanding the risk factors associated with these infections is paramount in developing effective strategies to reduce their incidence and improve patient care. Recent advancements in surgical techniques and postoperative care have undoubtedly improved the outcomes of cardiothoracic surgeries. 7 , 13 However, the risk of SSIs persists, partly due to the broad spectrum of patient demographics, comorbidities, and the intrinsic risk factors linked to these extensive procedures. The heterogeneity of the patient population undergoing cardiothoracic surgery, including variations in age, underlying health conditions and lifestyle factors such as smoking and alcohol use, further complicates the risk assessment for SSIs.
In our analysis, we have identified several key factors that significantly contribute to the increased risk of SSIs post‐cardiothoracic surgery. These include both modifiable factors, such as smoking and diabetes mellitus, and non‐modifiable factors, like patient age and inherent comorbidities. The results from the univariate and multivariate logistic regression analyses of risk factors for SSIs post‐cardiothoracic surgery provide critical insights into the complex interplay of patient characteristics and intraoperative factors contributing to SSIs. The strong association between smoking and SSIs, indicated by high chi‐square values and a significant odds ratio, could be attributed to the adverse effects of smoking on wound healing. Smoking impairs oxygenation and blood flow to the surgical site, which are crucial for tissue repair and immune responses. Nicotine, carbon monoxide, and other components in cigarette smoke have been shown to reduce collagen synthesis and fibroblast proliferation, essential for wound healing. 14 Thus, smoking may compromise the surgical site's resilience to infection. The significant link between diabetes mellitus and SSIs could be due to multiple factors. Poor glycaemic control often observed in diabetic patients can impair neutrophil function, reduce the production of growth factors, and alter collagen synthesis, all of which are vital for wound healing and infection control. Hyperglycaemia also creates a favourable environment for bacterial growth, thereby increasing the risk of SSIs. The use of drainage tubes, while essential in many surgical procedures, has been linked to an increased risk of SSIs. 15 , 16 Drainage tubes can act as a conduit for bacteria, facilitating the migration of pathogens from the skin surface to the surgical site. Additionally, their presence may cause local tissue trauma and inflammation, compromising the integrity of the wound and making it more susceptible to infection.
Smoking and diabetes mellitus elevate the risk of SSIs through distinct yet interrelated physiological mechanisms. 17 , 18 Smoking's vasoconstrictive effects critically limit blood and oxygen supply, essential for wound healing, and promote systemic inflammation, impairing immune response. 19 Diabetes mellitus exacerbates SSI risk via hyperglycaemia‐induced impairment of neutrophil function and phagocytosis, alongside vascular complications that mirror smoking's impact on blood flow. Particularly, hyperglycaemia fosters an environment conducive to bacterial proliferation at the surgical site. Additionally, peripheral neuropathy in diabetic patients complicates surgical wound management, further predisposing to SSIs. 20 Highlighting these mechanisms enriches our understanding of how modifiable risk factors like smoking and poorly controlled diabetes can significantly impact postoperative infection risks. Our study underscores the critical need for targeted preoperative interventions, including smoking cessation and strict glycaemic control, to mitigate these risks effectively.
Anaemia's association with higher SSI risk could be due to its impact on oxygen delivery to tissues. Adequate tissue oxygenation is crucial for effective immune responses and wound healing processes. Anaemia, by reducing haemoglobin levels, can impair oxygen transport to the surgical site, thus weakening the body's defence mechanisms against infections. 21 Significant intraoperative blood loss, as shown by the increased odds ratio for SSIs, can lead to hypoperfusion and tissue ischaemia at the surgical site. 22 This condition can severely impair immune cell function and wound healing, thereby increasing the vulnerability to infections. Additionally, blood transfusions, often required in cases of extensive blood loss, can further compromise immune function due to immunomodulatory effects. Interestingly, factors such as hypertension, hospital stay duration, alcohol consumption, age and BMI did not show a significant association with SSIs. This suggests that while these factors may influence overall health, their direct impact on SSIs may be less significant compared to the aforementioned factors. However, the borderline significance of prolonged operation time hints at the potential cumulative stress and exposure risk associated with longer surgical procedures. These findings underscore the importance of comprehensive preoperative assessments and targeted interventions to mitigate SSI risks. Strategies such as smoking cessation programmes, optimised glycaemic control in diabetic patients, judicious use of drainage tubes, careful monitoring and management of anaemia and minimising intraoperative blood loss could be vital. Personalising postoperative care based on these risk factors can significantly improve patient outcomes.
While our study provides valuable insights into the risk factors associated with SSIs post‐cardiothoracic surgery, several limitations should be acknowledged. Firstly, the retrospective nature of the study may lead to inherent biases, such as selection bias and information bias, potentially impacting the accuracy of the findings. Additionally, the study was conducted within a single institution, which may limit the generalisability of the results to broader populations with diverse demographics and healthcare settings. Another limitation is the potential for confounding variables that were not accounted for or measured in the study. Factors such as the specifics of surgical techniques, individual surgeon's experience, and variations in postoperative care protocols could have influenced the outcomes but were not explored in detail. Lastly, the relatively small sample size, especially in the group of patients who developed SSIs, might have limited the statistical power to detect more subtle associations between certain risk factors and the incidence of SSIs. Future studies with larger sample sizes and multicenter designs are needed to validate and expand upon our findings.
5. CONCLUSIONS
In conclusion, this study identifies intraoperative blood loss (≥800 mL), anaemia, drainage tube placement, smoking and diabetes mellitus as significant risk factors for SSIs in post‐cardiothoracic open surgery. Clinically, it is imperative to promptly recognise these factors in patients undergoing such procedures. Proactive and targeted preventive measures should be implemented to mitigate the risk and incidence of SSIs, thereby enhancing patient outcomes and postoperative care quality in cardiothoracic surgery.
CONFLICT OF INTEREST STATEMENT
The authors declare that they have no competing interests.
ETHICS STATEMENT
This study received approval from the Ethics Committee of Qionghai People's Hospital.
PATIENT CONSENT STATEMENT
Written informed consent for publication was obtained from all patients and their families included in this retrospective analysis.
Li H, Zheng X, Gao J. Extensive analysis of risk factors associated with surgical site infections post‐cardiothoracic open surgery. Int Wound J. 2024;21(3):e14842. doi: 10.1111/iwj.14842
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1. Grant MC. Regional for cardiac surgery: the devil is in the details. Ann Thorac Surg. 2022;114(5):1568. doi: 10.1016/j.athoracsur.2022.03.052 [DOI] [PubMed] [Google Scholar]
- 2. Tan NC. Cardiothoracic surgery. Ann Acad Med Singapore. 1992;21(2):190‐192. [PubMed] [Google Scholar]
- 3. Navarro R, Benavidez R. Nowadays open‐chest surgery in the era of fast‐track management. J Vis Surg. 2017;3:1. doi: 10.21037/jovs.2016.12.04 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Okay T, Ketenci B, Imamoglu OU, et al. Simultaneous open‐heart surgery and pectus deformity correction. Surg Today. 2008;38(7):592‐596. doi: 10.1007/s00595-007-3692-4 [DOI] [PubMed] [Google Scholar]
- 5. Giacobbe DR, Corcione S, Salsano A, et al. Current and emerging pharmacotherapy for the treatment of infections following open‐heart surgery. Expert Opin Pharmacother. 2019;20(6):751‐772. doi: 10.1080/14656566.2019.1574753 [DOI] [PubMed] [Google Scholar]
- 6. Gudbjartsson T, Jeppsson A, Sjögren J, et al. Sternal wound infections following open heart surgery ‐ a review. Scand Cardiovasc J. 2016;50(5–6):341‐348. doi: 10.1080/14017431.2016.1180427 [DOI] [PubMed] [Google Scholar]
- 7. Cvijanovic VS, Ristanović AS, Maric NT, et al. Surgical site infection incidence and risk factors in thoracic surgical procedures: a 12‐year prospective cohort study. J Infect Dev Ctries. 2019;13(3):212‐218. doi: 10.3855/jidc.11240 [DOI] [PubMed] [Google Scholar]
- 8. Yavuz S, Tarçın O, Ada S, et al. Incidence, aetiology, and control of sternal surgical site infections. J Hosp Infect. 2013;85(3):206‐212. doi: 10.1016/j.jhin.2013.07.010 [DOI] [PubMed] [Google Scholar]
- 9. Ohtsuka T. Management of postoperative surgical site infection and empyema after thoracic surgery. Kyobu Geka. 2023;76(10):874‐877. [PubMed] [Google Scholar]
- 10. Lai J, Li Q, He Y, Zou S, Bai X, Rastogi S. Glycemic control regimens in the prevention of surgical site infections: a meta‐analysis of randomized clinical trials. Front Surg. 2022;9:855409. doi: 10.3389/fsurg.2022.855409 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ata A, Lee J, Bestle SL, Desemone J, Stain SC. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145(9):858‐864. doi: 10.1001/archsurg.2010.179 [DOI] [PubMed] [Google Scholar]
- 12. Gudbjartsson T, Jeppsson A. Wound infections following open heart surgery ‐ review. Laeknabladid. 2019;105(4):177‐182. doi: 10.17992/lbl.2019.04.227 [DOI] [PubMed] [Google Scholar]
- 13. Morikane K. Epidemiology and risk factors associated with surgical site infection following surgery on thoracic aorta. Epidemiol Infect. 2018;146(14):1841‐1844. doi: 10.1017/s0950268818001930 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Colombier S, Kessler U, Ferrari E, von Segesser LK, Berdajs DA. Influence of deep sternal wound infection on long‐term survival after cardiac surgery. Med Sci Monit. 2013;19:668‐673. doi: 10.12659/msm.889191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Cheuk N, Worth LJ, Tatoulis J, Skillington P, Kyi M, Fourlanos S. The relationship between diabetes and surgical site infection following coronary artery bypass graft surgery in current‐era models of care. J Hosp Infect. 2021;116:47‐52. doi: 10.1016/j.jhin.2021.07.009 [DOI] [PubMed] [Google Scholar]
- 16. Ansari DM, Harahwa T, Abuelgasim E, Harky A. Glycated Haemoglobin levels and its effect on outcomes in cardiac surgery. Braz J Cardiovasc Surg (Torino). 2022;37(5):744‐753. doi: 10.21470/1678-9741-2020-0188 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Chang SA. Smoking and type 2 diabetes mellitus. Diabetes Metab J. 2012;36(6):399‐403. doi: 10.4093/dmj.2012.36.6.399 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Maddatu J, Anderson‐Baucum E, Evans‐Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101‐107. doi: 10.1016/j.trsl.2017.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Fujimoto D, Nomura Y, Egi M, Obata N, Mizobuchi S. Long‐term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice. BMC Endocr Disord. 2020;20(1):146. doi: 10.1186/s12902-020-00629-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Dasari N, Jiang A, Skochdopole A, et al. Updates in diabetic wound healing, inflammation, and scarring. Semin Plast Surg. 2021;35(3):153‐158. doi: 10.1055/s-0041-1731460 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Vitartaitė M, Vaičiulytė D, Venclovienė J, et al. Risk factors associated with an increased risk of deep sternal wound infections in patients after coronary artery bypass grafting and heart defect surgery. Heart Surg Forum. 2021;24(4):E741‐E745. doi: 10.1532/hsf.3935 [DOI] [PubMed] [Google Scholar]
- 22. Aeschbacher P, Nguyen TL, Dorn P, Kocher GJ, Lutz JA. Surgical site infections are associated with higher blood loss and open access in general thoracic practice. Front Surg. 2021;8:656249. doi: 10.3389/fsurg.2021.656249 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.